Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-01-16 @ 6:48 PM
Study NCT ID:
NCT06810895
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-02-06
First Post:
2024-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Sponsor:
Ding Ma
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TJ22-GYN/SCNEC -01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None